You are here:

budesonide (Budenofalk) Abbreviated

Advice

Following an abbreviated submission:

budesonide 9mg gastro-resistant granules (Budenofalk®) is accepted for use within NHS Scotland.

Indication under review: induction of remission in patients with active collagenous colitis.

Budesonide gastro-resistant granules provides a once daily alternative to budesonide gastro-resistant 3mg capsules (which are given three times daily) at no additional cost. The granules may have advantages for patients who have difficulty swallowing.

Drug Details

Drug Name: budesonide (Budenofalk) Abbreviated
SMC Drug ID: 831/12
Manufacturer: Dr Falk Pharma UK
Indication: Induction of remission in patients with active collagenous colitis.
BNF Category:
Sub Category: 1.5 Chronic bowel disorders
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 14 January 2013

Back